Worldwide prevalence of Toxocara infection among children: A systematic review and meta-analysis of an overlooked parasitic risk - Summary - MDSpire

Worldwide prevalence of Toxocara infection among children: A systematic review and meta-analysis of an overlooked parasitic risk

  • By

  • Nassim Rezapour

  • Helia Ghaffari Hamedani

  • Mahdi Sepidarkish

  • Nazanin Kianifard

  • Morteza Sheikhi Nooshabadi

  • Hamid Parsa

  • Kimia Bagheri

  • Maryam Ebrahimi

  • Mohsen Mohammadi

  • Neda Ahmadzadeh Tori

  • Seema Advani

  • Ashkan Garshasbi

  • Diba Mohammadi

  • Fatemeh Zahra Asadpour

  • Ali Rostami

  • December 29, 2025

  • 0 min

Share

Objective:

To quantify the burden of Toxocara infection specifically in children and establish age-stratified seroprevalence estimates.

Key Findings:
  • T-seroprevalence among children varies globally, with significant influences from environmental and socioeconomic factors.
Interpretation:

The findings highlight the significant public health impact of Toxocara infection in children, necessitating targeted interventions such as improved hygiene education and pet management.

Limitations:
  • Diagnostic variability and limited accessibility of serological tests in resource-poor regions may lead to underreporting of cases.
Conclusion:

This meta-analysis provides critical insights into the prevalence of Toxocara infection among children, emphasizing the need for enhanced public health strategies.

Original Source(s)

Worldwide prevalence of Toxocara infection among children: A systematic review and meta-analysis of an overlooked parasitic risk

  • by Nassim Rezapour, Helia Ghaffari Hamedani, Mahdi Sepidarkish, Nazanin Kianifard, Morteza Sheikhi Nooshabadi, Hamid Parsa, Kimia Bagheri, Maryam Ebrahimi, Mohsen Mohammadi, Neda Ahmadzadeh Tori, Seema Advani, Ashkan Garshasbi, Diba Mohammadi, Fatemeh Zahra Asadpour, Ali Rostami

  • December 29, 2025

Related Content

Gene Therapy Reaches XLRS Milestone

Atsena Therapeutics reports positive interim data for XLRS gene therapy

  • May 25, 2026

  • 3 min
Cladribine treatment in pediatric-onset multiple sclerosis: real-world clinical outcomes and safety insights

AI Falls Short on Differential Dx

New PrIME-LLM benchmark shows strong diagnostic accuracy but persistent gaps in clinical reasoning across 21 large language models